Andrea Rocca

7.0k total citations
135 papers, 4.1k citations indexed

About

Andrea Rocca is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrea Rocca has authored 135 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 56 papers in Cancer Research and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrea Rocca's work include Breast Cancer Treatment Studies (39 papers), Cancer Treatment and Pharmacology (33 papers) and HER2/EGFR in Cancer Research (31 papers). Andrea Rocca is often cited by papers focused on Breast Cancer Treatment Studies (39 papers), Cancer Treatment and Pharmacology (33 papers) and HER2/EGFR in Cancer Research (31 papers). Andrea Rocca collaborates with scholars based in Italy, United States and France. Andrea Rocca's co-authors include Aron Goldhirsch, Marco Colleoni, Laura Orlando, G. Peruzzotti, Giuseppe Viale, Elisabetta Pietri, Sara Bravaccini, Roberta Maltoni, Dino Amadori and Daniele Vallisa and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer.

In The Last Decade

Andrea Rocca

129 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Rocca Italy	33	2.3k	1.3k	1.1k	911	488	135	4.1k
Peter Vermeulen Belgium	35	2.3k 1.0×	1.3k 1.0×	1.4k 1.2×	776 0.9×	319 0.7×	79	4.0k
Gaia Schiavon United Kingdom	28	2.5k 1.1×	1.9k 1.5×	1.5k 1.4×	1.7k 1.9×	644 1.3×	105	4.6k
Yutaka Yamamoto Japan	36	1.7k 0.8×	1.7k 1.4×	1.6k 1.4×	743 0.8×	407 0.8×	194	3.9k
Andrea T. Hooper United States	32	2.6k 1.2×	1.2k 0.9×	2.8k 2.5×	645 0.7×	301 0.6×	56	5.8k
Lia Gore United States	43	2.6k 1.1×	632 0.5×	2.6k 2.3×	821 0.9×	763 1.6×	202	6.1k
Timothy G. Cooke United Kingdom	30	1.9k 0.8×	904 0.7×	1.2k 1.1×	399 0.4×	354 0.7×	64	3.4k
Anke Reinacher‐Schick Germany	30	3.1k 1.4×	1.4k 1.1×	1.3k 1.2×	1.1k 1.2×	868 1.8×	158	4.7k
Stylianos Kakolyris Greece	33	2.0k 0.9×	1.0k 0.8×	1.1k 0.9×	1.2k 1.3×	280 0.6×	151	3.5k
David R. Shalinsky United States	27	1.7k 0.8×	1.3k 1.0×	2.3k 2.0×	1.0k 1.1×	260 0.5×	52	4.3k
Kyung-Hun Lee South Korea	35	4.1k 1.8×	1.5k 1.2×	1.6k 1.5×	2.0k 2.2×	602 1.2×	216	6.0k

Countries citing papers authored by Andrea Rocca

Since Specialization

Citations

This map shows the geographic impact of Andrea Rocca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Rocca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Rocca more than expected).

Fields of papers citing papers by Andrea Rocca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Rocca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Rocca. The network helps show where Andrea Rocca may publish in the future.

Co-authorship network of co-authors of Andrea Rocca

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Rocca. A scholar is included among the top collaborators of Andrea Rocca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Rocca. Andrea Rocca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rocca, Andrea, Lucio Crinò, Luca Braga, et al.. (2025). Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies. British Journal of Cancer. 133(10). 1405–1427.

Salton, Francesco, Marianna Gabriella Rispoli, Paolo Confalonieri, et al.. (2024). A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids. The International Journal of Tuberculosis and Lung Disease. 28(9). 439–445. 2 indexed citations

Cortesi, Michela, Sara Bravaccini, Sara Ravaioli, et al.. (2024). HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer. Cancers. 16(22). 3752–3752.

Schettini, Francesco, Michela Palleschi, Fara Brasó‐Maristany, et al.. (2024). CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial. The Oncologist. 29(5). e622–e634. 4 indexed citations

Palleschi, Michela, Andrea Prochowski Iamurri, Emanuela Scarpi, et al.. (2022). Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab. Scientific Reports. 12(1). 3385–3385. 6 indexed citations

Rossi, Tania, Michela Tebaldi, Pietro Fici, et al.. (2022). Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis. Cancers. 14(16). 3925–3925. 9 indexed citations

Maltoni, Roberta, Michela Palleschi, Giulia Gallerani, et al.. (2020). Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer. Medicine. 99(24). e20396–e20396. 1 indexed citations

Nanni, Oriana, D. Amadori, Andrea De Censi, et al.. (2018). Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial. Breast Cancer Research and Treatment. 174(2). 433–442. 73 indexed citations

Tumedei, Maria Maddalena, Rosella Silvestrini, Sara Ravaioli, et al.. (2015). Role of Androgen and Estrogen Receptors as Prognostic and Potential Predictive Markers of Ductal Carcinoma in Situ of the Breast. The International Journal of Biological Markers. 30(4). 425–428. 14 indexed citations

10.

Corsi, Cristiana, Michele Aquilina, Andrea Casadei‐Gardini, et al.. (2013). Early detection of cardiotoxicity in chemotherapy-treated patients from real-time 3D echocardiography. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 40. 249–252. 6 indexed citations

11.

Rocca, Andrea, Giuseppe Cancello, Vincenzo Bagnardi, et al.. (2009). Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer.. PubMed. 29(12). 5111–9. 14 indexed citations

12.

Torrisi, Rosalba, Alessandra Balduzzi, R. Ghisini, et al.. (2007). Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel. Cancer Chemotherapy and Pharmacology. 62(4). 667–672. 75 indexed citations

13.

Rocca, Andrea, Giuseppe Viale, Richard D. Gelber, et al.. (2007). Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression. Cancer Chemotherapy and Pharmacology. 61(6). 965–971. 18 indexed citations

14.

Sandri, Maria Teresa, Harriet Johansson, Laura Zorzino, et al.. (2007). Serum EGFR and serum HER‐2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy. Cancer. 110(3). 509–517. 32 indexed citations

15.

Nolè, Franco, Chiara Catania, Elisabetta Munzone, et al.. (2006). Capecitabine/Vinorelbine: An Effective and Well-Tolerated Regimen for Women with Pretreated Advanced-Stage Breast Cancer. Clinical Breast Cancer. 6(6). 518–524. 25 indexed citations

16.

Rocca, Andrea, G. Peruzzotti, R. Ghisini, et al.. (2006). A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer. Anti-Cancer Drugs. 17(10). 1201–1209. 9 indexed citations

17.

Orlando, Laura, Anna Cardillo, R. Ghisini, et al.. (2006). Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer. BMC Cancer. 6(1). 225–225. 96 indexed citations

18.

Curigliano, Giuseppe, Gianluca Spitaleri, Elisabetta Pietri, et al.. (2005). Breast cancer vaccines: a clinical reality or fairy tale?. Annals of Oncology. 17(5). 750–762. 78 indexed citations

19.

Buscarini, L, Elisabetta Buscarini, M. Stasi, et al.. (2000). Percutaneous radiofrequency ablation of small hepatocellular carcinoma. Long term results. Ultrasound in Medicine & Biology. 26. 2 indexed citations

20.

Rocca, Andrea. (1995). [Reconstruction of the skin of the lower eyelid by orbito-nasolabial flap].. PubMed. 40(1). 46–52. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact